Sector Update: Health Care Stocks Advance Premarket Thursday

MT Newswires Live

Sep 18, 2025

Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) up 1%.

89bio (ETNB) stock was up more than 85% after the company said it has agreed to be acquired by Roche for $2.4 billion or a price of $14.50 per share in cash, a premium of about 79% above its closing Wednesday stock price.

Novo Nordisk (NVO) shares were up more than 7% after the company said its injectable Ozempic was linked to a 23% lower risk of heart attack, stroke, and death compared with dulaglutide in US Medicare patients with type 2 diabetes and cardiovascular disease.

Intellia Therapeutics (NTLA) shares were up more than 5% after the company said it has completed patient enrollment in a phase 3 study of lonvoguran ziclumeran for hereditary angioedema treatment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2568470438"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2568470438\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2568470438?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-18 21:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568470438","market":"us","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Advance Premarket Thursday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 1%.</p><p>89bio (ETNB) stock was up more than 85% after the company said it has agreed to be acquired by Roche for $2.4 billion or a price of $14.50 per share in cash, a premium of about 79% above its closing Wednesday stock price.</p><p><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> (NVO) shares were up more than 7% after the company said its injectable Ozempic was linked to a 23% lower risk of heart attack, stroke, and death compared with dulaglutide in US Medicare patients with type 2 diabetes and cardiovascular disease.</p><p><a href=\"https://laohu8.com/S/NTLA\">Intellia</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (NTLA) shares were up more than 5% after the company said it has completed patient enrollment in a phase 3 study of lonvoguran ziclumeran for hereditary angioedema treatment.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Advance Premarket Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Advance Premarket Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-18 21:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 1%.</p><p>89bio (ETNB) stock was up more than 85% after the company said it has agreed to be acquired by Roche for $2.4 billion or a price of $14.50 per share in cash, a premium of about 79% above its closing Wednesday stock price.</p><p><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> (NVO) shares were up more than 7% after the company said its injectable Ozempic was linked to a 23% lower risk of heart attack, stroke, and death compared with dulaglutide in US Medicare patients with type 2 diabetes and cardiovascular disease.</p><p><a href=\"https://laohu8.com/S/NTLA\">Intellia</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (NTLA) shares were up more than 5% after the company said it has completed patient enrollment in a phase 3 study of lonvoguran ziclumeran for hereditary angioedema treatment.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO.AU","symbol_name":"NOVO RESOURCES CORP-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2568470438","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2568470438","pubTimestamp":1758201058,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund  0.1% higher and the iShares Biotechnology ETF  up 1%.89bio  stock was up more than 85% after the company said it has agreed to be acquired by Roche for $2.4 billion or a price of $14.50 per share in cash, a premium of about 79% above its closing Wednesday stock price.Novo Nordisk  shares were up more than 7% after the company said its injectable Ozempic was linked to a 23% lower risk of heart attack, stroke, and death compared with dulaglutide in US Medicare patients with type 2 diabetes and cardiovascular disease.Intellia Therapeutics  shares were up more than 5% after the company said it has completed patient enrollment in a phase 3 study of lonvoguran ziclumeran for hereditary angioedema treatment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO.AU":"NOVO RESOURCES CORP-CDI","BK4007":"制药","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4532":"文艺复兴科技持仓","BK4581":"高盛持仓","BK4599":"减肥药","BK4556":"基因编辑","BK4585":"ETF&股票定投概念","XLV":"健康照护类股ETF-SPDR","BK4139":"生物科技","ETNB":"89Bio, Inc.","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK7104":"黄金","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","NVO":"诺和诺德","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4535":"淡马锡持仓","IBB":"生物科技指数ETF-iShares Nasdaq","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","NTLA":"Intellia Therapeutics Inc","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD"},"translate_title":"行业更新：医疗保健股周四盘前上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1,"XBI":0.6,"NVO.AU":1,"ETNB":1,"IBB":1,"NTLA":1,"XLV":1},"content_text":"Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) up 1%.89bio (ETNB) stock was up more than 85% after the company said it has agreed to be acquired by Roche for $2.4 billion or a price of $14.50 per share in cash, a premium of about 79% above its closing Wednesday stock price.Novo Nordisk (NVO) shares were up more than 7% after the company said its injectable Ozempic was linked to a 23% lower risk of heart attack, stroke, and death compared with dulaglutide in US Medicare patients with type 2 diabetes and cardiovascular disease.Intellia Therapeutics (NTLA) shares were up more than 5% after the company said it has completed patient enrollment in a phase 3 study of lonvoguran ziclumeran for hereditary angioedema treatment.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}